Evidence map›Paper›PMID 41218819›Full record

ArticleBrain tumor research and treatment2025

Erdheim-Chester Disease Mimicking a Malignant Pituitary Stalk Tumor With Ventricular Dissemination: A Case Report.

Myungsuk Oh, Se Hoon Kim, Eui Hyun Kim

Abstract readCase Reports
In one paragraph

Article in Brain tumor research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Myungsuk OhDepartment of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0009-9666-9238
Se Hoon KimDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7516-7372
Eui Hyun KimDepartment of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2523-7122

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erdheim-Chester disease (ECD) is a rare form of non-Langerhans cell histiocytosis characterized by multi-organ involvement, most commonly affecting the long bones, retroperitoneum, heart, lungs, skin, and central nervous system (CNS). Approximately half of reported cases exhibit CNS involvement, which may affect both intra- and extra-axial compartments. On MRI, ECD typically presents as a strongly enhancing mass lesion, often mimicking neoplastic or infectious conditions. With advances in genetic understanding, ECD is now recognized as a hematologic malignancy of histiocytic origin, driven by mutations in key components of the MAPK signaling pathway. Among these, the

Indexed as

CSF1RErdheim-Chester diseaseHistiocytic malignancyInflammatory pseudotumorPituitary stalk

Identifiers

PMID41218819
PMCPMC12621855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.